HIKAL INKS DEAL
Listen beyond the noise from Trump, think beyond Nifty’s volatility: 8 mid and 1 small cap pharma stock with upside potential of up to 46%With the Nifty moving up for just two days, have we forgotten what happened to stock prices in the past six months? This is where we all ma...
Hikal inks 10-year multi-product deal with global pharma company for APIsThe company has signed a multi-year contract with a leading global pharmaceutical company. This contract entails the development and supply...
- Load More